It’s not just drugmakers reshaping the pharmaceutical sector; distributors are rapidly transforming, too. While most investors and policymakers focus on rising prescription drug prices or ...
Licensing deal transactions are confidential, and there can be long waits before royalties from market sales are realized, so it can be difficult to make generalizations about their total value and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results